...
首页> 外文期刊>Nucleic acids research >The hybridization-stabilization assay: a solution-based isothermal method for rapid screening and determination of sequence preference of ligands that bind to duplexed nucleic acids
【24h】

The hybridization-stabilization assay: a solution-based isothermal method for rapid screening and determination of sequence preference of ligands that bind to duplexed nucleic acids

机译:杂交稳定化验:一种基于溶液的等温方法,用于快速筛选和确定与双链体核酸结合的配体的序列偏好

获取原文

摘要

The gene-to-drug quest will be most directly served by the discovery and development of small molecules that bind to nucleic acids and modulate gene expression at the level of transcription and/or inhibit replication of infectious agents. Full realization of this potential will require implementation of a complete suite of modern drug discovery technologies. Towards this end, here we describe our initial results with a new assay for identification and characterization of novel nucleic acid binding ligands. It is based on the well recognized property of stabilization of hybridization of complementary oligonucleotides by groove and/or intercalation binding ligands. Unlike traditional thermal melt methodologies, this assay is isothermal and, unlike gel-based footprinting techniques, the assay also is performed in solution and detection can be by any number of highly sensitive, non-radioisotopic modalities, such as fluorescence resonance energy transfer, described herein. Thus, the assay is simple to perform, versatile in design and amenable to miniaturization and high throughput automation. Assay validation was performed using various permutations of direct and competitive binding formats and previously well studied ligands, including pyrrole polyamide and intercalator natural products, designed hairpin pyrrole–imidazole polyamides and furan-based non-polyamide dications. DNA specific ligands were identified and their DNA binding site size and sequence preference profiles were determined. A systematic approach to studying the relationship of binding sequence specificity with variation in ligand structure was demonstrated, and preferred binding sites in longer DNA sequences were found by pseudo-footprinting, with results that are in accord with established findings. This assay methodology should promote a more rapid discovery of novel nucleic acid ligands and potential drug candidates.
机译:通过发现和开发与核酸结合并在转录水平上调节基因表达和/或抑制感染因子复制的小分子,将最直接地满足基因对药物的探索。要充分发挥这种潜力,就需要实施一套完整的现代药物发现技术。为此,在这里我们用一种新方法来描述我们的初步结果,该方法用于鉴定和表征新型核酸结合配体。它基于公认的通过凹槽和/或插入结合配体稳定互补寡核苷酸杂交的特性。与传统的热熔方法不同,该测定是等温的,并且与基于凝胶的印迹技术不同,该测定也可以在溶液中进行,并且可以通过多种高度敏感的非放射性同位素方式进行检测,例如荧光共振能量转移在这里。因此,该测定法易于执行,设计通用并且适于小型化和高通量自动化。使用直接和竞争性结合形式的各种排列以及先前经过充分研究的配体(包括吡咯聚酰胺和嵌入剂天然产物,设计的发夹吡咯-咪唑聚酰胺和呋喃基非聚酰胺药物)进行测定验证。鉴定DNA特异性配体,并测定其DNA结合位点大小和序列偏好性。证明了系统的方法来研究结合序列特异性与配体结构变化之间的关系,并且通过伪足迹发现了更长的DNA序列中的首选结合位点,其结果与既定发现相符。这种测定方法应该促进更快速地发现新型核酸配体和潜在的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号